Eric J. Hyllengren - 31 Mar 2025 Form 4 Insider Report for Atara Biotherapeutics, Inc. (ATRA)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
02 Apr 2025, 19:54:05 UTC
Prior SEC filing
05 Mar 2025
Next SEC filing
17 Jul 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ John Chao, Attorney-in-Fact for Eric J. Hyllengren

Key filing fact

Eric J. Hyllengren filed Form 4 for Atara Biotherapeutics, Inc. (ATRA) on 02 Apr 2025.

Key facts

  • This page summarizes Eric J. Hyllengren's Form 4 filing for Atara Biotherapeutics, Inc. (ATRA).
  • 10 reported transactions and 10 derivative rows are listed below.
  • Accepted by SEC: 02 Apr 2025, 19:54.

Change

  • Previous filing in this sequence was filed on 05 Mar 2025.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ATRA transaction Derivative

Employee Stock Option (Right to Buy)

Disposed to Issuer

Transaction value
$0
Shares
-1,900
Change %
-100%
Price
$0.000000
Shares after
0
Date
31 Mar 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
1,900
Exercise price
$996.25
Footnotes
F4
ATRA transaction Derivative

Employee Stock Option (Right to Buy)

Disposed to Issuer

Transaction value
$0
Shares
-460
Change %
-100%
Price
$0.000000
Shares after
0
Date
31 Mar 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
460
Exercise price
$961.75
Footnotes
F4
ATRA transaction Derivative

Employee Stock Option (Right to Buy)

Disposed to Issuer

Transaction value
$0
Shares
-496
Change %
-100%
Price
$0.000000
Shares after
0
Date
31 Mar 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
496
Exercise price
$303.75
Footnotes
F4
ATRA transaction Derivative

Employee Stock Option (Right to Buy)

Disposed to Issuer

Transaction value
$0
Shares
-154
Change %
-100%
Price
$0.000000
Shares after
0
Date
31 Mar 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
154
Exercise price
$303.75
Footnotes
F1, F4
ATRA transaction Derivative

Employee Stock Option (Right to Buy)

Disposed to Issuer

Transaction value
$0
Shares
-381
Change %
-100%
Price
$0.000000
Shares after
0
Date
31 Mar 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
381
Exercise price
$427.63
Footnotes
F4
ATRA transaction Derivative

Employee Stock Option (Right to Buy)

Disposed to Issuer

Transaction value
$0
Shares
-350
Change %
-100%
Price
$0.000000
Shares after
0
Date
31 Mar 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
350
Exercise price
$427.63
Footnotes
F2, F4
ATRA transaction Derivative

Employee Stock Option (Right to Buy)

Disposed to Issuer

Transaction value
$0
Shares
-262
Change %
-100%
Price
$0.000000
Shares after
0
Date
31 Mar 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
262
Exercise price
$255.25
Footnotes
F4
ATRA transaction Derivative

Employee Stock Option (Right to Buy)

Disposed to Issuer

Transaction value
$0
Shares
-543
Change %
-77%
Price
$0.000000
Shares after
160
Date
31 Mar 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
543
Exercise price
$255.25
Footnotes
F3, F4
ATRA transaction Derivative

Employee Stock Option (Right to Buy)

Disposed to Issuer

Transaction value
$0
Shares
-331
Change %
-100%
Price
$0.000000
Shares after
0
Date
31 Mar 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
331
Exercise price
$97.75
Footnotes
F4
ATRA transaction Derivative

Employee Stock Option (Right to Buy)

Disposed to Issuer

Transaction value
$0
Shares
-8,961
Change %
-77%
Price
$0.000000
Shares after
2,656
Date
31 Mar 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
8,961
Exercise price
$97.75
Footnotes
F3, F4
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

Eric J. Hyllengren is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Explanation of responses 4 footnotes

Footnote F1

1/11th of the shares subject to the stock option vested and became exercisable on May 1, 2023, and the remaining shares vested in equal monthly installments over the following ten (10) months, subject to the reporting person's continuous service.

Footnote F2

1/23rd of the shares subject to the stock option vested and became exercisable on May 1, 2023, and the remaining shares vested in equal monthly installments over the following twenty-two (22) months, subject to the reporting person's continuous service.

Footnote F3

1/35th of the shares subject to the stock option vested and became exercisable on May 1, 2023, and the remaining shares vest in equal monthly installments over the following thirty-four (34) months, subject to the reporting person's continuous service.

Footnote F4

This option was cancelled by mutual agreement of the Issuer and the reporting person, in exchange for which cancellation the reporting person will receive a total cash payment of $100 as consideration.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .